Minerva Surgical has announced the appointment of Darin Hammers as its new President and Chief Executive Officer, as well as a member of its Board of Directors. With a career spanning 30 years, Hammers brings a wealth of expertise and leadership, particularly in the development and commercialization of minimally invasive gynecologic technologies aimed at improving patient outcomes.
Hammers' most recent role was as President and CEO of EndoGastric Solutions (EGS), which was acquired by Merit Medical in July. His previous positions include CEO of DYSIS Medical and President and CEO of Cogentix Medical, a company acquired by Laborie in 2018. Additionally, Hammers served as Vice President of Sales for the Bard Medical Division of C.R. Bard and held various leadership roles within the Urology and Gynecology division at Boston Scientific Corporation over a span of twelve years.
Throughout his tenure in the medical device industry, Hammers has consistently demonstrated an ability to build high-performing organizations and teams, delivering exceptional results. Minerva Surgical's Chairman, Dr. Uri Geiger, expressed enthusiasm about Hammers' appointment, stating, "We are delighted to welcome Darin as our new President and Chief Executive Officer. Mr. Hammers is a dynamic business leader with exceptional strategic capabilities, proven operational effectiveness and strong experience in women’s health. The Board looks forward to working with Darin as we grow Minerva’s platform of exceptional products for women’s care."
Hammers himself remarked, "I am delighted to join Minerva Surgical and build a company that will develop new and innovative technologies to improve the quality of life for women. The core portfolio of products is as effective as any on the market when it comes to treating uterine cavity conditions, and the goal is to expand our footprint in the gynecology space and become a market leader."
Hammers holds an MBA from Emory University’s Goizueta School of Business and a Bachelor of Science degree in marketing from the University of Southern Indiana.
This leadership change marks a significant moment for Minerva Surgical, a company that focuses on minimally invasive solutions to meet the distinct uterine healthcare needs of women. The appointment of Hammers could potentially accelerate the company's growth and innovation in the gynecology sector. Minerva Surgical has already established a broad product line of minimally invasive alternatives to hysterectomy, designed to address common causes of Abnormal Uterine Bleeding (AUB) in various uterine anatomies. These solutions aim to preserve the uterus and avoid unnecessary hysterectomies, making them a crucial option in women's healthcare.
For more information about Minerva Surgical's innovative medical devices, please visit their website.
